Feature | Cath Lab | September 12, 2017

Cardiovascular Research Foundation Appointed Juan Granada as New President, CEO

Distinguished cardiologist takes the helm of key interventional cardiology organization, sponsor of TCT

Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as the foundation’s president and chief executive officer (CEO). CRF sponsors TCT.

The Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as the foundation’s president and chief executive officer (CEO).

September 12, 2017 – The Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as the foundation’s president and chief executive officer (CEO). Granada was also appointed to CRF’s Board of Directors. A renowned leader in cardiology, he joined CRF in 2007 and served as executive director and chief innovation officer at the CRF Skirball Center for Innovation. He is also an assistant professor of medicine at Columbia University College of Physicians and Surgeons. 

Granada also has served as a member of the Editorial Board for Diagnostic and Interventional Cardiology (DAIC) magazine since 2010.

“Juan’s proven leadership skills, along with his expertise across preclinical, clinical, and educational initiatives will help CRF strengthen and expand its role in the development of innovative new technologies and therapies that will benefit people with heart disease worldwide,” said Eric B. Woldenberg, Esq., chairman of the CRF Board of Directors and a senior partner at Pryor Cashman LLP.

“Since its inception, CRF has played a major role in the rapid progress that has been made in interventional cardiology by establishing the safe use of new technologies and therapies for heart disease,” Granada said. “I am eager to take on this new role and work with my distinguished colleagues to ignite the next wave of innovation that will help doctors save and improve the quality of their patients’ lives.”

“CRF has grown due to a special blend of passion, creativity, and productivity, and Juan embodies our innovative culture,” said Martin B. Leon, M.D., founder and chairman emeritus of CRF and its co-director, medical research and education. “With his unique combination of advanced interventional skills, entrepreneurial spirit, and business insight, he has the visionary capacity to foresee new opportunities. Importantly, Juan is a caring and thoughtful people person who will catalyze communication and collaboration both inside and outside the organization.”

“Juan’s professionalism, creativity and ‘can do’ mindset make him an exceptional individual for this position,” added Gregg W. Stone, M.D., CRF’s co-director of medical research and education. “His knowledge of interventional cardiovascular medicine from bench to bedside coupled with extensive expertise in medical innovation will propel CRF to new levels of achievement in research and education.”

Granada is one of the world’s foremost investigators in the translational validation of novel cardiovascular therapies. He has helped develop and successfully validate several endovascular imaging and device technologies. He received his medical degree from the Institute of Health Sciences in Medellin, Colombia and finished his cardiovascular disease and interventional cardiology fellowships at Baylor College of Medicine in Houston, Texas.  

 

Video and Article Interviews With Dr. Juan Granada:

VIDEO: Bioresorbable Stent Failure Modes, Technique, Patient Selection and Future Development

VIDEO: Transcatheter Mitral Valve Technology, Anatomical Challenges

Advances and Future Directions for Transcatheter Valves

VIDEO: Transcatheter Mitral Valve Therapies in Development — TVT 2015

VIDEO: The Evolution of TAVR Technology — TVT 2015

Transcatheter Mitral Valve Replacement Devices in Development

Drug-eluting Balloons Enter the U.S. Market

Advances in Intravascular Imaging

 

For more information: www.crf.org

Related Content

Survey data showing opinions of physicians and hospital administrators on barriers to implementing new technology and how new technologies have improved cardiovascular care.

Survey data showing opinions of physicians and hospital administrators on barriers to implementing new technology and how new technologies have improved cardiovascular care.

News | Cardiovascular Business | September 14, 2020
September 14, 2020 — New global research released by Abbott takes a deep dive into the barriers of cardiovascular pat
Philips angiography system in a cath lab at Henry Ford Hospital.
Feature | Cardiovascular Business | July 13, 2020 | Deb Thompson and Christian Comeau
For a cardiovascular service line leader, addressing challenges in an evolving healthcare climate is a constant.
Leeds Hospital recently installed Philips Azurion angiography interventional labs to enhance procedural guidance capabilities.

Leeds Hospital recently installed Philips Azurion angiography interventional labs to enhance procedural guidance capabilities.

News | Cardiovascular Business | July 08, 2020
July 8, 2020 – Philips Healthcare and Leeds Teaching Hospitals NHS Trust announced a seven-year managed service agree
Medicare will pay for telehealth virtual doctor visits during the duration of the coronavirus COVID-19 outbreak.
News | Cardiovascular Business | March 17, 2020
March 17, 2020 — The Trump Administration today announced expanded Medicare telehealth coverage that will enable bene
Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Cardiovascular Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
 Cath Lab Philips Azurion angiography PCI
News | Cardiovascular Business | December 30, 2019
December 30, 2019 — Most patients do not understand or recall information given to them before heart procedures.
Siemens Healthineers Acquires ECG Management Consultants
News | Cardiovascular Business | November 11, 2019
November 11, 2019 — ECG Management Consultants, a leading U.S.